Leptin selectively decreases visceral adiposity and enhances insulin action.
Intraabdominal adiposity and insulin resistance are risk factors for diabetes mellitus, dyslipidemia, arteriosclerosis, and mortality. Leptin, a fat-derived protein encoded by the ob gene, has been postulated to be a sensor of energy storage in adipose tissue capable of mediating a feedback signal to sites involved in the regulation of energy homeostasis. Here, we provide evidence for specific effects of leptin on fat distribution and in vivo insulin action. Leptin (LEP) or vehicle (CON) was administered by osmotic minipumps for 8 d to pair-fed adult rats. During the 8 d of the study, body weight and total fat mass decreased similarly in LEP and in CON. However, while moderate calorie restriction (CON) resulted in similar decreases in whole body (by 20%) and visceral (by 21%) fat, leptin administration led to a specific and marked decrease (by 62%) in visceral adiposity. During physiologic hyperinsulinemia (insulin clamp), leptin markedly enhanced insulin action on both inhibition of hepatic glucose production and stimulation of glucose uptake. Finally, leptin exerted complex effects on the hepatic gene expression of key metabolic enzymes and on the intrahepatic partitioning of metabolic fluxes, which are likely to represent a defense against excessive storage of energy in adipose depots. These studies demonstrate novel actions of circulating leptin in the regulation of fat distribution, insulin action, and hepatic gene expression and suggest that it may play a role in the pathophysiology of abdominal obesity and insulin resistance.
Barzilai
N
N
Diabetes Research and Training Center, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Wang
J
J
Massilon
D
D
Vuguin
P
P
Hawkins
M
M
Rossetti
L
L
D000273:Adipose Tissue / Q000502:physiology*; D000818:Animals; D001786:Blood Glucose; D001835:Body Weight; D004435:Eating; D015870:Gene Expression; D005947:Glucose / Q000378:metabolism; D007328:Insulin / Q000378:metabolism*; D020738:Leptin; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D011506:Proteins / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000494:pharmacology; D014781:Viscera / Q000378:metabolism
D001786:Blood Glucose; D007328:Insulin; D020738:Leptin; D011506:Proteins; D011994:Recombinant Proteins; D005947:Glucose